Uncovering GLP-1s | E03: The Truth About Obesity In India: Uncensored | Earlyfit | Novo Nordisk

Описание: Uncover the truth about obesity with two of India's leading endocrinologists, Dr. Saptarshi Bhattacharya and Dr. Simran Thakkar, hosted by Saloni Paliwal, co-founder at Earlyfit, in a special World Obesity Day collaboration with Novo Nordisk.
Obesity is not a lack of willpower, it is a chronic, relapsing metabolic disease. And for Indians, the risks run deeper than most realise. In this episode, we unpack why "eat less, move more" isn't enough, what's really driving India's obesity epidemic, and why 250 million Indians are at risk right now.

We will cover:
▪️ Why obesity is a disease, not a lifestyle failure
▪️ The "Thin Fat Phenotype": Why Indians carry dangerous visceral fat even when they look slim
▪️ The role of GLP-1 & GIP hormones in appetite, insulin resistance & weight loss
▪️ Why muscle & protein are non-negotiable for metabolic health
▪️ The real cost: Treating obesity vs. paying for its complications
Inspired?
🔗 Visit: https://www.novocare.in/ https://early.fit/

Follow us on Instagram:
@novonordisk @joinearly.fit


⏱️ Timestamps:
00:00 Intro
02:00 Fat or Obese? There's a Difference & It Matters
04:19 The Thin Fat Phenotype: Why Indians Are at Higher Risk
05:35 Silent Disease: Feeling Fine But Still at Risk
07:55 The #1 Lifestyle Change for Weight Loss
09:00 Why Protein & Strength Training Matter More Than You Think
10:22 GLP-1 & GIP Hormones Explained
16:20 Are medical interventions a shortcut?
17:00 Risks vs. Benefits: How Doctors Evaluate Treatment
18:45 Common Myths: "I'll Lose My Glow" & Other Misconceptions
19:32 250 million Indians are obese. Why?
21:14 The Cost of NOT Treating Obesity
22:33 Closing Advice: How to Start Your Weight Loss Journey Safely

#weightloss #glp1 #obesity #metabolichealth #insulinresistance #EarlyFit #NovoNordisk #WorldObesityDay #semaglutide #tirzepatide #bariatrichealth #longevity #healthpodcast #endocrinology #thinfatphenotype #obesityinIndia

⚠️ Disclaimer: For people living with over weight and obesity weight management outcomes may vary depending on their treatment journeys, which should be pursued under the guidance of a registered healthcare professional. Ref: Dent Ret al. Metabolism. 2020 Dec 1;113:154388
This information is for educational purposes only and is not meant to replace medical advice. Always reach out to your registered healthcare professional for more information. Apis Bull logo is a registered trademark of Novo Nordisk A/S. Medical references: Horn et al. Postgrad Med 2022; 134:359-75. Wharton Set al. CMAJ. 2020 Aug 4;192(31):E875-E891.